Department of Plastic and Reconstructive Surgery, School of Medicine, Kyungpook National University, 130 Dongdeok-ro, Daegu, 41944, Korea.
Leaders Plastic Surgery Clinic, Daegu, Korea.
Aesthetic Plast Surg. 2021 Jun;45(3):853-863. doi: 10.1007/s00266-020-01981-y. Epub 2020 Sep 29.
Autologous lipotransfer has increasingly become popular for breast reconstruction. Moreover, owing to the emergence of information regarding the efficacy of stromal vascular fraction (SVF) in terms of oncological safety and survival rate, procedures based on cell-assisted lipotransfer (CAL) have been widely employed recently. However, quantitative data of CAL with SVF are lacking. We evaluated the efficacy of CAL using SVF on survival rate in breast reconstruction.
A 12-month prospective study was conducted for 20 patients (20 breasts) requiring breast asymmetry correction due to volume deficit following autologous breast reconstruction using a transverse rectus abdominis myocutaneous flap or latissimus dorsi flap after total mastectomy. After the patients were equally divided into two groups-fat graft with SVF (Group 1, n = 10) and without SVF (Group 2, n = 10)-, the variance of breast volume was measured using three-dimensional scanning to analyze fat graft retention rate. Moreover, patient satisfaction and complications were investigated.
Fat graft retention rate was higher in Group 1 than in Group 2 at both postoperative 6 months (73.8% vs. 62.2%; p = 0.03) and 12 months (65.4% vs. 48.4%; p = 0.03). Group 1 showed higher patient satisfaction. Regarding complications, fat necrosis occurred in 1 patient each in both groups. However, locoregional recurrence was not observed in any patient during follow-up.
CAL with SVF is effective in increasing survival rates of autologous fat grafts for correction of volume deficit after breast reconstruction. Moreover, it is associated with improved patient satisfaction in terms of the esthetic aspect.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
自体脂肪转移越来越多地用于乳房重建。此外,由于基质血管成分 (SVF) 在肿瘤安全性和生存率方面的疗效信息的出现,基于细胞辅助脂肪转移 (CAL) 的手术最近得到了广泛应用。然而,CAL 联合 SVF 的定量数据尚缺乏。我们评估了 SVF 在乳房重建中对生存率的影响。
对 20 例(20 侧乳房)接受全乳切除术后使用横行腹直肌肌皮瓣或背阔肌皮瓣进行自体乳房重建的患者进行了 12 个月的前瞻性研究,这些患者由于体积不足需要进行乳房不对称矫正。将患者等分为两组:含 SVF 的脂肪移植组(第 1 组,n = 10)和不含 SVF 的脂肪移植组(第 2 组,n = 10),使用三维扫描测量乳房体积的变化,以分析脂肪移植的保留率。此外,还调查了患者的满意度和并发症。
第 1 组的脂肪移植保留率在术后 6 个月(73.8% vs. 62.2%;p = 0.03)和 12 个月(65.4% vs. 48.4%;p = 0.03)均高于第 2 组。第 1 组患者的满意度更高。关于并发症,两组各有 1 例出现脂肪坏死。然而,在随访期间,没有患者出现局部复发。
SVF 联合 CAL 可有效提高乳房重建后体积不足的自体脂肪移植的成活率。此外,它在美容方面与提高患者满意度相关。
证据等级 IV:本杂志要求作者为每篇文章分配一个证据等级。有关这些循证医学等级的完整描述,请参考目录或在线作者指南www.springer.com/00266。